Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. Until recently only a few products had reached the market for a limited number of indications.
In this webinar, oncology market research experts Sue Marett, Phil Rosenberg and Claire Fradet Aubignat will explore the key features of the immuno-oncology market and outline the critical success factors that manufacturers need to consider in order to remain competitive.
Find out more: http://www.researchpartnership.com/news/2016/11/webinar-immuno-oncologys-evolution/